Role of NADPH oxidases in the redox biology of liver fibrosis

Redox Biology

Volumn 6, Issue , 2015, Pages 106-111

  Crosas Molist, Eva ^a   Fabregat, Isabel ^a,b  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hepatocyte; Inflammation; Myofibroblast; NOX; Stellate cell; TGF beta

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; ANTIOXIDANT; ANTIVIRUS AGENT; ENZYME INHIBITOR; SCLEROPROTEIN;

APOPTOSIS; CELL ACTIVATION; CELL DEATH; CELL FUNCTION; CELL TRANSDIFFERENTIATION; DISEASE COURSE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; LIVER CELL; LIVER FIBROSIS; MITOCHONDRION; MYOFIBROBLAST; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; STELLATE CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; HEPATIC STELLATE CELL; LIVER CIRRHOSIS; METABOLISM; MOUSE; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; ANTIOXIDANTS; ANTIVIRAL AGENTS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; HEPATIC STELLATE CELLS; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; MEMBRANE TRANSPORT MODULATORS; MICE; MYOFIBROBLASTS; NADPH OXIDASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84937571378     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.07.005     Document Type: Review

References (68)

1. Xue Z.-F., Wu X.-M., Liu M. Hepatic regeneration and the epithelial to mesenchymal transition. World J. Gastroenterol. 2013, 19:1380-1386. 10.3748/wjg.v19.i9.1380.
2. Mallat A., Lotersztajn S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am. J. Physiol. Cell Physiol. 2013, 305:C789-C799. 10.1152/ajpcell.00230.2013.
3. Schuppan D., Kim Y.O. Evolving therapies for liver fibrosis. J. Clin. Invest. 2013, 123:1887-1901. 10.1172/JCI66028.
4. Iwaisako K., Jiang C., Zhang M., Cong M., Moore-Morris T.J., Park T.J., et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E3297-E3305. 10.1073/pnas.1400062111.
5. Czaja A.J. Hepatic inflammation and progressive liver fibrosis in chronic liver disease. World J. Gastroenterol. 2014, 20:2515-2532. 10.3748/wjg.v20.i10.2515.
6. Barnes J.L., Gorin Y. Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 2011, 79:944-956. 10.1038/ki.2010.516.
7. Fabregat I., Sancho P. The Transforming Growth Factor-Beta (TGF-β) in liver fibrosis. TGF-Β in Human Disease 2013, 255-277. Springer. A. Moustakas, K. Miyazawa (Eds.).
8. Brenner C., Galluzzi L., Kepp O., Kroemer G. Decoding cell death signals in liver inflammation. J. Hepatol. 2013, 59:583-594. 10.1016/j.jhep.2013.03.033.
9. Kitamura K., Nakamoto Y., Akiyama M., Fujii C., Kondo T., Kobayashi K., et al. Pathogenic roles of tumor necrosis factor receptor p55-mediated signals in dimethylnitrosamine-induced murine liver fibrosis. Lab. Investig. J. Tech. Methods Pathol. 2002, 82:571-583.
10. Seki E., De Minicis S., Osterreicher C.H., Kluwe J., Osawa Y., Brenner D.A., et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13:1324-1332. 10.1038/nm1663.
11. Lambeth JD NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 2004, 4:181-189. 10.1038/nri1312.
12. Liu W., Baker S.S., Baker R.D., Zhu L. Antioxidant mechanisms in nonalcoholic fatty liver disease. Curr. Drug Targets 2015.
13. Dunning S., Ur Rehman A., Tiebosch M.H., Hannivoort R.A., Haijer F.W., Woudenberg J., et al. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death. Biochim. Biophys. Acta 2013, 1832:2027-2034. 10.1016/j.bbadis.2013.07.008.
14. Paik Y.-H., Kim J., Aoyama T., De Minicis S., Bataller R., Brenner D.A. Role of NADPH oxidases in liver fibrosis. Antioxid. Redox Signal. 2013, 20:2854-2872. 10.1089/ars.2013.5619.
15. Novo E., Busletta C., Bonzo L.V., di, Povero D., Paternostro C., Mareschi K., et al. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. J. Hepatol. 2011, 54:964-974. 10.1016/j.jhep.2010.09.022.
16. Foo N.-P., Lin S.-H., Lee Y.-H., Wu M.-J., Wang Y.-J. α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β. Toxicology 2011, 282:39-46. 10.1016/j.tox.2011.01.009.
17. Abhilash P.A., Harikrishnan R., Indira M. Ascorbic acid supplementation down-regulates the alcohol induced oxidative stress, hepatic stellate cell activation, cytotoxicity and mRNA levels of selected fibrotic genes in guinea pigs. Free Radic. Res. 2012, 46:204-213. 10.3109/10715762.2011.647691.
18. Yadav D., Hertan H.I., Schweitzer P., Norkus E.P., Pitchumoni C.S. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C. Am. J. Gastroenterol. 2002, 97:2634-2639. 10.1111/j.1572-0241.2002.06041.x.
19. Pawlak K., Zolbach K., Borawski J., Mysliwiec M., Kovalchuk O., Chyczewski L., et al. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients. Thromb. Res. 2008, 123:166-170. 10.1016/j.thromres.2008.02.012.
20. MacDonald G.A., Bridle K.R., Ward P.J., Walker N.I., Houglum K., George D.K., et al. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J. Gastroenterol. Hepatol. 2001, 16:599-606.
21. Seki S., Kitada T., Sakaguchi H. Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. 2005, 33:132-134. 10.1016/j.hepres.2005.09.020.
22. Anavi S., Ni Z., Tirosh O., Fedorova M. Steatosis-induced proteins adducts withlipid peroxidation products and nuclear electrophilic stress in hepatocytes. Redox Biol. 2015, 4:158-168. 10.1016/j.redox.2014.12.009.
23. Weston C.J., Shepherd E.L., Claridge L.C., Rantakari P., Curbishley S.M., Tomlinson J.W., et al. Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. J. Clin. Investig. 2015, 125:501-520. 10.1172/JCI73722.
24. Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194:7-15. 10.1083/jcb.201102095.
25. Samarakoon R., Dobberfuhl A.D., Cooley C., Overstreet J.M., Patel S., Goldschmeding R., et al. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species. Cell Signal. 2013, 25:2198-2209. 10.1016/j.cellsig.2013.07.007.
26. Holmström K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014, 15:411-421. 10.1038/nrm3801.
27. Guichard C., Moreau R., Pessayre D., Epperson T.K., Krause K.-H. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?. Biochem. Soc. Trans. 2008, 36:920-929. 10.1042/BST0360920.
28. Hecker L., Vittal R., Jones T., Jagirdar R., Luckhardt T.R., Horowitz J.C., et al. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 2009, 15:1077-1081. 10.1038/nm.2005.
29. Masamune A., Watanabe T., Kikuta K., Satoh K., Shimosegawa T. NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G99-108. 10.1152/ajpgi.00272.2007.
30. Sedeek M., Callera G., Montezano A., Gutsol A., Heitz F., Szyndralewiez C., et al. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 2010, 299:F1348-F1358. 10.1152/ajprenal.00028.2010.
31. Bondi C.D., Manickam N., Lee D.Y., Block K., Gorin Y., Abboud H.E., et al. NAD(P)H oxidase mediates TGF-β1-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 2010, 21:93-102. 10.1681/ASN.2009020146.
32. Cucoranu I., Clempus R., Dikalova A., Phelan P.J., Ariyan S., Dikalov S., et al. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 2005, 97:900-907. 10.1161/01.RES.0000187457.24338.3D.
33. De Minicis S., Seki E., Paik Y.-H., Österreicher C.H., Kodama Y., Kluwe J., et al. Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology 2010, 52:1420-1430. 10.1002/hep.23804.
34. Cui W., Matsuno K., Iwata K., Ibi M., Matsumoto M., Zhang J., et al. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 2011, 54:949-958. 10.1002/hep.24465.
35. Paik Y.-H., Iwaisako K., Seki E., Inokuchi S., Schnabl B., Osterreicher C.H., et al. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Hepatology 2011, 53:1730-1741. 10.1002/hep.24281.
36. Zhan S.-S., Jiang J.X., Wu J., Halsted C., Friedman S.L., Zern M.A., et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 2006, 43:435-443. 10.1002/hep.21093.
37. Chan E.C., Peshavariya H.M., Liu G.-S., Jiang F., Lim S.-Y., Dusting G.J. Nox4 modulates collagen production stimulated by transforming growth factor β1 in vivo and in vitro. Biochem. Biophys. Res. Commun. 2013, 430:918-925. 10.1016/j.bbrc.2012.11.138.
38. Sampson N., Koziel R., Zenzmaier C., Bubendorf L., Plas E., Jansen-Dürr P., et al. ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol. Endocrinol. 2011, 25:503-515. 10.1210/me.2010-0340.
39. Jiang F., Liu G.-S., Dusting G.J., Chan E.C. NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses. Redox Biol. 2014, 2:267-272. 10.1016/j.redox.2014.01.012.
40. Proell V., Carmona-Cuenca I., Murillo M.M., Huber H., Fabregat I., Mikulits W. TGF-beta dependent regulation of oxygen radicals during transdifferentiation of activated hepatic stellate cells to myofibroblastoid cells. Comp. Hepatol. 2007, 6:1. 10.1186/1476-5926-6-1.
41. Jiang J.X., Chen X., Serizawa N., Szyndralewiez C., Page P., Schroder K., et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831 a novel NOX4/NOX1 inhibitor in vivo. Free Radic. Biol. Med. 2012, 53:289-296. 10.1016/j.freeradbiomed.2012.05.007.
42. Sancho P., Mainez J., Crosas-Molist E., Roncero C., Fernandez-Rodriguez C.M., Pinedo F., et al. NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS ONE 2012, 7. 10.1371/journal.pone.0045285.
43. Bettaieb A., Jiang J.X., Sasaki Y., Chao T.-I., Kiss Z., Chen X., et al. Hepatocyte NADPH oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice. Gastroenterology 2015, 10.1053/j.gastro.2015.04.009.
44. Aram G., Potter J.J., Liu X., Wang L., Torbenson M.S., Mezey E. Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology 2009, 49:911-919. 10.1002/hep.22708.
45. Jiang J.X., Venugopal S., Serizawa N., Chen X., Scott F., Li Y., et al. Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 2010, 139:1375-1384. 10.1053/j.gastro.2010.05.074.
46. Sancho P., Martín-Sanz P., Fabregat I. Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway. Free Radic. Biol. Med. 2011, 51:1789-1798. 10.1016/j.freeradbiomed.2011.08.011.
47. Jiang J.X., Venugopal S., Serizawa N., Chen X., Scott F., Li Y., et al. NOX2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 2010, 139. 1375-84.e4. 10.1053/j.gastro.2010.05.074.
48. Herrera B., Murillo M.M., Alvarez-Barrientos A., Beltrán J., Fernández M., Fabregat I. Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic. Biol. Med. 2004, 36:16-26. 10.1016/j.freeradbiomed.2003.09.020.
49. Carnesecchi S., Deffert C., Donati Y., Basset O., Hinz B., Preynat-Seauve O., et al. A key role for NOX4 in epithelial cell death during development of lung fibrosis. Antioxid. Redox Signal. 2011, 15:607-619. 10.1089/ars.2010.3829.
50. Carmona-Cuenca I., Roncero C., Sancho P., Caja L., Fausto N., Fernández M., et al. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J. Hepatol. 2008, 49:965-976. 10.1016/j.jhep.2008.07.021.
51. Caja L., Sancho P., Bertran E., Iglesias-Serret D., Gil J., Fabregat I. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-β-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res. 2009, 69:7595-7602. 10.1158/0008-5472.CAN-09-1482.
52. Sancho P., Bertran E., Caja L., Carmona-Cuenca I., Murillo M.M., Fabregat I. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. Biochim. Biophys. Acta 2009, 1793:253-263. 10.1016/j.bbamcr.2008.09.003.
53. Sancho P., Fabregat I. The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-β-induced apoptosis of liver tumor cells. Biochem. Pharmacol. 2011, 81:917-924. 10.1016/j.bcp.2011.01.007.
54. Tsochatzis E.A., Bosch J., Burroughs A.K. Liver cirrhosis. Lancet 2014, 383:1749-1761. 10.1016/S0140-6736(14)60121-5.
55. Jia D., Duan F., Peng P., Sun L., Ruan Y., Gu J. Pyrroloquinoline-quinone suppresses liver fibrogenesis in mice. PloS One 2015, 10:e0121939. 10.1371/journal.pone.0121939.
56. Serviddio G., Bellanti F., Stanca E., Lunetti P., Blonda M., Tamborra R., et al. Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis. Free Radic. Biol. Med. 2014, 73:117-126. 10.1016/j.freeradbiomed.2014.05.002.
57. Martínez-Chantar M.L., Corrales F.J., Martínez-Cruz L.A., García-Trevijano E.R., Huang Z.-Z., Chen L., et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2002, 16:1292-1294. 10.1096/fj.02-0078fje.
58. Von Montfort C., Matias N., Fernandez A., Fucho R., Conde de la Rosa L., Martinez-Chantar M.L., et al. Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J. Hepatol. 2012, 57:852-859. 10.1016/j.jhep.2012.05.024.
59. Den Hartog G.J.M., Qi S., van Tilburg J.H.O., Koek G.H., Bast A. Superoxide anion radicals activate hepatic stellate cells after entry through chloride channels: a new target in liver fibrosis. Eur. J. Pharmacol. 2014, 724:140-144. 10.1016/j.ejphar.2013.12.033.
60. Lin W., Wu G., Li S., Weinberg E.M., Kumthip K., Peng L.F., et al. HIV and HCV cooperatively promote hepatic fibrogenesis via induction of reactive oxygen species and NFkappaB. J. Biol. Chem. 2011, 286:2665-2674. 10.1074/jbc.M110.168286.
61. Kawata K., Kobayashi Y., Souda K., Kawamura K., Sumiyoshi S., Takahashi Y., et al. Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. Antioxid. Redox Signal. 2010, 13:259-268. 10.1089/ars.2009.2903.
62. Grattagliano I., Palmieri V.O., Portincasa P., Minerva F., Palasciano G. Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients. Clin. Biochem. 2011, 44:1400-1404. 10.1016/j.clinbiochem.2011.09.008.
63. Yang Y., Zhao Z., Liu Y., Kang X., Zhang H., Meng M. Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1-AMP-activated protein kinase signaling. J. Gastroenterol. Hepatol. 2015, 30:609-618. 10.1111/jgh.12723.
64. Hernández-Gea V., Hilscher M., Rozenfeld R., Lim M.P., Nieto N., Werner S., et al. Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J. Hepatol. 2013, 59:98-104. 10.1016/j.jhep.2013.02.016.
65. Altenhöfer S., Radermacher K.A., Kleikers P.W.M., Wingler K., Schmidt H.H.H.W. Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement. Antioxid. Redox Signal. 2014, 10.1089/ars.2013.5814.
66. Aoyama T., Paik Y.-H., Watanabe S., Laleu B., Gaggini F., Fioraso-Cartier L., et al. Nicotinamide adenine dinucleotide phosphate oxidase (NOX) in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatolology 2012, 56:2316-2327. 10.1002/hep.25938.
67. Senturk S., Mumcuoglu M., Gursoy-Yuzugullu O., Cingoz B., Akcali K.C., Ozturk M. Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology 2010, 52:966-974. 10.1002/hep.23769.
68. Crosas-Molist E., Bertran E., Sancho P., López-Luque J., Fernando J., Sánchez A., et al. The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression. Free Radic. Biol. Med. 2014, 69:338-347. 10.1016/j.freeradbiomed.2014.01.040.